Skip to main content
. 2022 Sep 28;13:929677. doi: 10.3389/fimmu.2022.929677

Figure 4.

Figure 4

Dendritic cell miRNAs regulate pro- and anti-tumor immune responses in the TME. Dendritic cells are a central hub for priming pro- and anti-tumor immune responses in cancer. Many DC miRNAs change TAA presentation to and co-stimulation of T cells, required for T-cell–mediated anti-tumor immunity. Several other miRNAs suppress the proinflammatory functions and promote the immune suppressive function of DCs.